US Broker Ratings

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 32.76% Upside for Investors

AptarGroup, Inc. (NYSE: ATR) is making waves in the healthcare sector with its diversified portfolio of drug delivery and consumer product dispensing solutions. Headquartered in Crystal Lake, Illinois, AptarGroup serves..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating Strong Sector Potential Amidst Market Challenges

Tenet Healthcare Corporation (NYSE: THC) stands as a significant player within the U.S. healthcare sector, commanding a robust market capitalization of $17.94 billion. With a diverse operational footprint, Tenet offers..

Takeda Pharmaceutical Company (TAK) Stock Analysis: Investor Outlook with a 23% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector and one of Japan’s most venerable corporations, offers a compelling proposition for investors, particularly with a potential upside..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Healthcare Sector with Stable Cash Flow and Mixed Analyst Ratings

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector’s medical instruments and supplies industry, presents an intriguing case for investors seeking exposure to the critical products and services..

Abbott Laboratories (ABT) Stock Analysis: Potential Upside and Robust Dividend Yield

Abbott Laboratories (NYSE: ABT) is a prominent player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $234.25 billion, Abbott has established itself as..

Zoetis Inc. (ZTS) Stock Analysis: Unlocking a 29% Potential Upside in Animal Health

Zoetis Inc. (NYSE: ZTS) stands as a formidable player in the animal health sector, a niche yet crucial branch of the healthcare industry. With a robust market capitalization of $64.89..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Navigating a $205 Billion Market Cap with Promising Analyst Ratings

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, is a formidable presence in the diagnostics and research industry, boasting a market capitalization of $205.16 billion. Headquartered..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating the Healthcare Sector’s Growth Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN), a leading player in the healthcare sector, has been making waves in the medical devices industry. With a market cap of $15.43 billion,..

Royalty Pharma (RPRX) Stock Analysis: Unlocking a 23.72% Potential Upside in the Biotech Sector

Royalty Pharma plc (NASDAQ: RPRX) stands at the forefront of biopharmaceutical innovation, serving as a crucial financier and purchaser of biopharmaceutical royalties. With a robust market cap of $21.04 billion,..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and Growth Prospects Highlight Investment Potential

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, has been making waves in the specialty and generic drug manufacturing industry. With a market capitalization of $20.49..

West Pharmaceutical Services (WST) Stock Analysis: A Promising 16% Upside Within the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a key player within the healthcare sector, has attracted considerable investor attention given its significant potential upside and robust market positioning. With a market..

McKesson Corporation (MCK) Stock Analysis: Unpacking a 12.4% Potential Upside in Healthcare Distribution

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a pivotal player in the medical distribution industry. With a market capitalization of $91.8 billion, McKesson has entrenched..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Healthcare Giant Poised for 6.47% Upside

Dr. Reddy’s Laboratories Ltd (RDY), a stalwart in the healthcare sector, is making waves in the drug manufacturing industry with its robust portfolio of specialty and generic products. Headquartered in..

Genmab A/S (GMAB) Stock Analysis: Attractive Upside Potential with Robust Growth Prospects

Genmab A/S (NASDAQ: GMAB) has been capturing the attention of investors with its strong foothold in the biotechnology sector and a promising pipeline of antibody-based products aimed at treating cancer..

Haleon plc (HLN) Stock Analysis: A 29.97% Potential Upside in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, Haleon plc (NYSE: HLN) presents a compelling case with its substantial market presence and promising growth prospects. With a market capitalization of..

The Cigna Group (CI) Investor Outlook: Assessing 17.94% Potential Upside and Strong Buy Ratings

For investors navigating the dynamic landscape of healthcare stocks, The Cigna Group (NYSE: CI) stands out as a compelling opportunity. With a robust market capitalization of $83.01 billion and a..

Koninklijke Philips N.V. (PHG): Investor Outlook Reveals 19% Potential Upside Amid Healthcare Sector Dynamics

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare industry, continues to capture investor attention with its diverse portfolio and strategic positioning in the medical devices sector. Based..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth with a 7.57% Potential Upside

For investors eyeing opportunities in the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) presents a compelling case. As a leading player in the medical instruments and supplies industry, Becton,..

Alcon Inc. (ALC) Stock Analysis: A 25.75% Upside Potential with Strong Buy Ratings

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly in the niche of medical instruments and supplies, presents an intriguing opportunity for individual investors. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 13.10% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the healthcare sector, is a prominent player in the medical devices industry, particularly known for its advanced cardiovascular disease treatments. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds